BiotechTube
Home/Ichnos Glenmark Innovation/Mario Perro, Ph.D.
MP

Mario Perro, Ph.D.

Chief Scientific Officer

Ichnos Glenmark Innovation

Therapeutic Areas

Oncology

Ichnos Glenmark Innovation Pipeline

DrugIndicationPhase
ISB 2001Multiple MyelomaPhase 1b
ISB 2301Oncology (unspecified)Preclinical
GRC 65327Oncology (unspecified)Preclinical

Leadership Team at Ichnos Glenmark Innovation

LP
Lida Pacaud, M.D.
Chief Executive Officer
View full Ichnos Glenmark Innovation profile